These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34832847)

  • 1. The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia.
    Lustyk K; Sałaciak K; Zaręba P; Siwek A; Sapa J; Pytka K
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
    Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
    Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
    Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Arylpiperazine Derivatives of Salicylamide with α
    Żmudzka E; Lustyk K; Siwek A; Wolak M; Gałuszka A; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBK-10, A Compound with α
    Lustyk K; Sałaciak K; Siwek A; Filipek B; Sapa J; Marona H; Żelaszczyk D; Pytka K
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
    Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities.
    Kubacka M; Mogilski S; Filipek B; Marona H
    Eur J Pharmacol; 2013 Nov; 720(1-3):237-46. PubMed ID: 24161912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
    Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers.
    Yang W; Wang W; Cai S; Li P; Zhang D; Ning J; Ke J; Hou A; Chen L; Ma Y; Jin W
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia/reperfusion in rats.
    Rapacz A; Sapa J; Pytka K; Dudek M; Filipek B; Szkaradek N; Marona H
    Pharmacol Rep; 2015 Dec; 67(6):1163-7. PubMed ID: 26481536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J
    Acta Pol Pharm; 2010; 67(5):537-42. PubMed ID: 20873423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.
    Kotańska M; Kulig K; Marcinkowska M; Bednarski M; Malawska K; Zaręba P
    J Endocrinol Invest; 2018 May; 41(5):609-619. PubMed ID: 29110282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
    Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
    Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
    Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.